Navigation Links
New York Genome Center Launches Groundbreaking Consortium to Accelerate Scientific and Clinical Discoveries
Date:9/19/2013

NEW YORK, Sept. 19, 2013 /PRNewswire/ -- The New York Genome Center (NYGC) officially launched its scientific and clinical consortium of academic and industry leaders focused on harnessing genomics to advance the understanding and treatment of disease.  The announcement was made at the start of NYGC's inaugural scientific symposium with New York City Mayor Michael Bloomberg speaking at a ribbon cutting ceremony.

The two-day scientific symposium kicks off the opening of NYGC's new 170,000 square foot research facility in Manhattan and brings together leaders of 16 member institutions to discuss the importance of genomics research for the detection, diagnosis, and treatment of human disease.

The symposium features a number of prominent speakers, including Dr. Harold Varmus, Director of the National Cancer Institute, Marc Tessier-Lavigne, President of The Rockefeller University, Nobel Laureate Dr. James Watson, Cold Spring Harbor Laboratory, and Dr. Tom Maniatis, Chairman of the Department of Biochemistry and Molecular Biophysics at Columbia University and Chair of NYGC's Scientific and Clinical Steering Committee, as well as panelists discussing Pharmacogenomics, Genomics, Quantified Health, and the Future of Big Data on Patient Care.

"The opening of the New York Genome Center is a major achievement in the City's ongoing efforts to advance the bioscience sector in New York City – part of our commitment to diversify the city's economy and create jobs," said Mayor Bloomberg. "The Genome Center's new facility and its groundbreaking approach to collaboration will help solve some of medicine's most challenging problems by bringing together the city's best academic and clinical institutions."

"We applaud
'/>"/>

SOURCE New York Genome Center
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Life Technologies and OpGen Sign Collaborative Agreement to Leverage Ion Torrent and Whole Genome Mapping Technologies
2. Qualyst Transporter Solutions, LLC Announces New Alliance with GenoMembrane
3. Global BioClinical Awarded Cancer Genome Atlas (TCGA) Contract
4. GenomeDx Expands Collaboration with Mayo Clinic
5. Second Genome Announces Agreement with Janssen on Microbiome Drug Discovery in Ulcerative Colitis
6. Sangamo BioSciences Announces Notice Of Allowance For New Patent Application Covering Genome Modification Technology
7. Sigma Life Science Launches CRISPR/Cas Genome Editing Tools
8. BGI Tech and South Texas Accelerated Research Therapeutics Initiate Collaboration to Advance Unique San Antonio 1000 Cancer Genome Project
9. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  Now available for sale, The Armor1 Ankle Roll ... ankle sprains by cushioning the ankle from an inversion ... the outside of any shoe type and allows the ... offering protection against sprains. With customers in physical therapy, ...
(Date:1/23/2015)... , Jan. 23, 2015   Leatt Corporation  (OTCQB: ... protective equipment for all forms of sports, including extreme ... neck brace, announced today that the UISP Lega Motociclismo ... requires all riders to wear a neck brace during ...
(Date:1/23/2015)... , January 23, 2015 Heptares Therapeutics, the ... to announce that the Malcolm Campbell Memorial Prize ... (Vice President of Chemistry), Fiona Marshall (Chief Scientific ... Officer and co-founder) for the seminal contributions to GPCR drug ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... Group -, BRISBANE, Calif., May 28 ... clinical trials program through the,initiation of an additional ... The trial will assess BSI-201, the first ADP-ribose ... for the treatment,of uterine carcinosarcoma or malignant mixed ...
... C and LymphoStat-B(R) for lupus on track for ... potential launch in 2010 -,- ABthrax(TM) for inhalation anthrax on track to begin delivery fall ... ... - GSK to advance darapladib to Phase 3 for atherosclerosis -, ROCKVILLE, ...
Cached Medicine Technology:BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer 2Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 2Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 3Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 4Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 5Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 6Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 7Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 8Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 9Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 10Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 11
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together by ... up to 30lbs in less than 12 weeks without traditional ... prompting an investigative review. , “Our Incredible Bulk review ... that allows the body to pack on a massive amount ...
(Date:1/22/2015)... January 22, 2015 Blue Cross and Blue ... who exemplify what it means to “Live Fearless.” ... people to share their stories about how they or someone ... inspired others by living in the moment. By telling these ...
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District of ... C.R. Bard, Inc. in that proceeding’s first bellwether trial. In ... request for a new trial after finding that C.R. Bard ...
(Date:1/22/2015)... A new white paper by The Beryl Institute ... long-term care environment as well as provides recommendations for ... “The Power of Person-Centeredness in Long-Term Care: A View ... patient, resident and family experience in long-term care and ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2
... LAVAL, QC, Feb. 26 /PRNewswire-FirstCall/ - BELLUS Health Inc. ... quarter ended December 31, 2008, and commented on the ... the fourth quarter, the Company reports a net loss ... per share) for the corresponding period in the previous ...
... business unit joins the global rare disease community to ... unite patient communityCAMBRIDGE, Mass., Feb. 26 Shire Human ... the global specialty biopharmaceutical company, today announced it will ... (NORD) to celebrate World Rare Disease Day on February ...
... Autism" and Provides Important Information on Early Warning ... and Babies"R"Us stores nationwide will kick off a ... the nation,s leading organization dedicated to increasing awareness ... causes, prevention and treatments for autism; and advocating ...
... Evidence-Based Recommendations for All Levels of SocietyWASHINGTON, Feb. ... that approximately 45 percent of colon cancer cases ... the US are preventable through diet, physical activity ... for policies to reduce the global number of ...
... SANTA ANA, Calif., Feb. 26 MIND Research Institute ... of Advanced,Medical Optics (AMO), was recently elected to MIND,s ... education. He serves on numerous boards and,committees at the ... chairs the UCI,Foundation,s Board of Trustees, the Engineering Advisory ...
... of colon and breast,cancer cases in some countries are ... maintenance, according to estimates in a,report that has set ... The report, Policy and Action ... (WCRF) and American Institute for Cancer Research,(AICR), has estimated ...
Cached Medicine News:Health News:BELLUS Health reports results for the fourth quarter of 2008 2Health News:BELLUS Health reports results for the fourth quarter of 2008 3Health News:BELLUS Health reports results for the fourth quarter of 2008 4Health News:BELLUS Health reports results for the fourth quarter of 2008 5Health News:BELLUS Health reports results for the fourth quarter of 2008 6Health News:BELLUS Health reports results for the fourth quarter of 2008 7Health News:BELLUS Health reports results for the fourth quarter of 2008 8Health News:BELLUS Health reports results for the fourth quarter of 2008 9Health News:BELLUS Health reports results for the fourth quarter of 2008 10Health News:BELLUS Health reports results for the fourth quarter of 2008 11Health News:BELLUS Health reports results for the fourth quarter of 2008 12Health News:BELLUS Health reports results for the fourth quarter of 2008 13Health News:BELLUS Health reports results for the fourth quarter of 2008 14Health News:BELLUS Health reports results for the fourth quarter of 2008 15Health News:BELLUS Health reports results for the fourth quarter of 2008 16Health News:BELLUS Health reports results for the fourth quarter of 2008 17Health News:BELLUS Health reports results for the fourth quarter of 2008 18Health News:BELLUS Health reports results for the fourth quarter of 2008 19Health News:BELLUS Health reports results for the fourth quarter of 2008 20Health News:BELLUS Health reports results for the fourth quarter of 2008 21Health News:BELLUS Health reports results for the fourth quarter of 2008 22Health News:BELLUS Health reports results for the fourth quarter of 2008 23Health News:BELLUS Health reports results for the fourth quarter of 2008 24Health News:BELLUS Health reports results for the fourth quarter of 2008 25Health News:Shire Celebrates World Rare Disease Day on February 28 2Health News:Shire Celebrates World Rare Disease Day on February 28 3Health News:Shire Celebrates World Rare Disease Day on February 28 4Health News:Toys'R'Us and Babies'R'Us Launch In-Store Fundraising Campaign to Benefit Autism Speaks 2Health News:Toys'R'Us and Babies'R'Us Launch In-Store Fundraising Campaign to Benefit Autism Speaks 3Health News:Report: Many Cancers Could Be Prevented in US 2Health News:Jim Mazzo Joins MIND Research Institute's Board of Directors 2Health News:Landmark Report: Many Cancers Could be Prevented 2
Mounted on a remarkably lightweight and,flexible cotton headband with crown strap,the Sport is fully adjustable....
... putty is a product of AlloSource, ... in human tissue processing, and Interpore ... technology. InterGro combines AlloGro DBM ... to deliver a unique bone graft ...
... highest bone content (93% by volume) of ... offers excellent handling characteristics, which will enhance ... used alone or as a graft extender ... Place, The high molecular weight biocompatible carrier ...
... ICON DS Strep A is a qualitative assay ... throat swabs. The ICON DS Strep A test ... in rare and low positive colonization samples. This ... With outstanding performance, ICON DS Strep A leaves ...
Medicine Products: